The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions
Abstract Background The burden of advanced non-small cell lung cancer (NSCLC) is not well understood, and the number of patients likely to receive treatment in Europe has not been quantified. The aim of this study was to forecast the annual number of patients with squamous and non-squamous advanced...
Main Authors: | David Campbell, Ken O’Day, Nadine Hertel, John R. Penrod, Melinda Manley Daumont, Michael Lees |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | Population Health Metrics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12963-018-0174-4 |
Similar Items
-
Evidence of a higher burden of multimorbidity among female patients in Albania
by: Ledio Collaku, et al.
Published: (2018-04-01) -
Evidence of a higher burden of multimorbidity among female patients in Albania
by: Ledio Collaku, et al.
Published: (2018-04-01) -
A conceptual model of treatment burden and patient capacity in stroke
by: Katie I. Gallacher, et al.
Published: (2018-01-01) -
Improving continuity of patient care across sectors: study protocol of a quasi-experimental multi-centre study regarding an admission and discharge model in Germany (VESPEERA)
by: Johanna Forstner, et al.
Published: (2019-03-01) -
An economic evaluation of nivolumab for the treatment of squamous and non-squamous NSCLC in the Swedish setting
by: Caitlin Smare, et al.
Published: (2019-12-01)